GSK Gets Fines Slashed In UK Pay-For-Delay Case
GlaxoSmithKline has convinced the United Kingdom's competition appeal body to significantly slash the £37.6 million ($53.1 million) fine it was hit with half a decade ago for paying to keep generic...To view the full article, register now.
Already a subscriber? Click here to view full article